BioNexus Gene Lab Corp Company Profile
NASDAQ: BGLCHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioNexus Gene Lab at a glance
BioNexus Gene Lab Corp (NASDAQ: BGLC) is a Medical Specialities company in the Health Care sector headquartered in Kuala Lumpur, Malaysia. BioNexus Gene Lab is led by Mr. Su-Leng Tan and employs about 19 people. At a market capitalization of $2.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001737523, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does BioNexus Gene Lab do?
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Business description based on the company's public filings.
Company information
- Legal name
- BioNexus Gene Lab Corp
- Ticker
- NASDAQ: BGLC
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Su-Leng Tan
- Employees
- 19
- Headquarters
- Menara UOA Bangsar, Kuala Lumpur, Malaysia
- Phone
- 60 1 307 241 6898
- Website
- bionexusgenelab.com
- Market cap
- $1.99M
- SEC CIK
- 0001737523
- Latest annual report
- 10-K · Apr 14, 2026
Companies similar to BioNexus Gene Lab
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ADVBAdvanced Biomed Inc. | 1.65 | -5.71% | $2.73M | vs BGLC |
| ACONAclarion Inc. | 1.22 | -13.92% | $3.52M | vs BGLC |
| AMSAmerican Shared Hospital Services | 1.00 | -4.76% | $6.67M | vs BGLC |
| MDXHMDxHealth SA | 0.1074 | -8.52% | $10.25M | vs BGLC |
| SERASera Prognostics Inc. Class A | 1.81 | -4.23% | $71.98M | vs BGLC |
| BDSXBiodesix Inc. | 7.56 | -8.92% | $83.83M | vs BGLC |
| XGNExagen Inc. | 3.61 | -5.00% | $92.10M | vs BGLC |
| KEQUKewaunee Scientific Corporation | 33.55 | -2.75% | $97.14M | vs BGLC |